Drug intelligence / Profile preview

United Biomedical LHRH vaccine

Development stage
Unknown
Lead developer
United Biomedical
Modality
Peptides, Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

The United Biomedical LHRH vaccine is a synthetic peptide-based vaccine designed for immunocastration and reproductive control in animals, particularly livestock. It targets luteinizing hormone-releasing hormone (LHRH), also known as gonadotropin-releasing hormone (GnRH). The vaccine works by inducing the production of antibodies that neutralize endogenous GnRH, thereby suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This hormonal suppression leads to the inhibition of gonadal function, effectively achieving castration or reproductive control without surgical intervention. It is primarily used to manage boar taint in swine and control reproductive behaviors and fertility in various animal species, offering a more humane alternative to traditional surgical methods.

Other names
United Biomedical GnRH vaccineLHRH immunocastration vaccineGnRH immunocastration vaccinesynthetic peptide LHRH vaccineLHRH vaccineGnRH vaccine
02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)

Beyond the preview

Go deeper on United Biomedical LHRH vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on United Biomedical LHRH vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call